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Endometriosis affects nearly 10% of all women of reproductive age, and it is a significant source of pelvic pain and infertility. When excessive fibrosis occurs, lesions form scar tissue and alter tissue function. Standard treatment options are fairly limited; surgery risks complete organ removal without a guaranteed cure. Many questions remain as to what causes endometriosis and which mechanisms contribute to its development.
Jing Li et al. [1] addressed this knowledge gap by explaining endometriosis on a cellular and mechanistic level. They proposed paracrine factors secreted by mesenchymal stem cells as contributors to epithelial edge ingrowth, collagen synthesis, differentiation into wound-healing cells, and angiogenesis-all factors for fibrogenesis.
Endometriotic and endometrial stem cells (Ecto-and EutoESCs) were treated with mesenchymal stem cell-conditioned medium. After a variety of assays, endometriotic mesenchymal stem cell (Ecto-MSC)-conditioned medium consistently showed higher expression of genes involved in fibrogenesis when compared to control and endometrial mesenchymal stem cell (Euto-MSC)-conditioned medium. Specifically, EctoMSCs secreted higher levels of profibrotic factors TGF-b1 and Wnt1 compared to Euto-MSCs taken from the same source.
To confirm the role of TGF-b1 and Wnt1 in fibrogenesis, a TGF-b1 neutralizing antibody and Wnt1 negative regulator (Dickkopf-related protein) was used in stromal cell culture and compared to uninhibited groups. The latter showed elevated levels of certain profibrotic mRNA, particularly in the TGF-b1 plus Wnt1 group. In the inhibited groups, these profibrotic factors were reduced.
Jing Li et al. next focused on the canonical Wnt pathway (already known for influencing systemic fibrotic diseases and isolated organ fibrosis) to clarify the pathway used by these paracrine factors. By measuring the nuclear accumulation of bcatenin, they traced varying activation of this pathway across different points of incubation in Ecto-MSCs. This varying expression did not manifest in control groups.
In vitro mouse studies provided more evidence for EctoMSCs being the primary factors responsible for promoting fibrosis, which is associated with deep-infiltrating endometriosis. When treated with culture medium from profibrotic factors, each group showed endometriotic lesions within glandular structures and stroma 14 days after treatment. The control group showed none.
There may be still other potential contributing factors and pathways to this disease, but this study offers specific targets for innovative stem cell therapies that could treat endometriosis and possibly reverse damage caused by fibrosis. The results also offer key markers that could be identified in the disease's early stages for swift diagnoses.
